期刊文献+

核酸疫苗双表达载体的构建及表达 被引量:1

Construction and Expression of Co-Expression Vector for DNA Vaccine
下载PDF
导出
摘要 将微小病毒内部核糖体进入位点(IRES)基因克隆到质粒pVAXI载体多克隆位点,构建出核酸疫苗双表达载体pVI。将绿色荧光蛋白(EGFP)基因和新霉素磷酸转移酶(neor)基因作为报告基因,连接到pVI载体IRES基因的前后两处多克隆位点,构建出表达载体pEIN。通过脂质体介导的方法将该载体转染COS-7细胞,筛选到同时表达绿色荧光蛋白和新霉素磷酸转移酶的表达株,表明成功地构建了核酸疫苗双表达载体,为构建多价核酸疫苗及带有分子佐剂的核酸疫苗打下了基础。 Internal ribosome entry site (IRES) gene was cloned into plasmid pVAXI to construct a eukaryotic co-expression plasmid pVI for DNA vaccine. Then enhanced green fluorescent protein (EGFP) gene and neomycin phosphotransferase (neo^r) gene fragment were ligated with pVI as reporter genes into its two multiple cloned sites by IRES respectively to construct co-expression plasmid pEIN containing two expression units of EGFP and neor. Recombinant vector was transfected into COS-7 cell by means of lipid mixtures. The cell expressing the two proteins was obtained by screening. The successful construction of the eukaryotic co-expression vector became the foundation for multivalency DNA vaccine and DNA vaccine containing molecular adjuvant.
出处 《微生物学杂志》 CAS CSCD 2006年第5期37-39,共3页 Journal of Microbiology
关键词 IRES EGFP neo^r 转染 IRES EGFP neo^r transfection
  • 相关文献

参考文献5

  • 1Wild J,Gruner B,Metzger K,et al.Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid[J].Vaccine,1998,16:353-360.
  • 2Tahara H,Zitvogel L,Storkus WJ,et al.Effective eradication of established murine tumors with Il-12 gene therapy using a polycistronic retroviral vector[J].J Immunol,1995,154(12):6 466-6 474.
  • 3Major ME,Vitvitski L,Mink MA,et al.DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid[J].J Virology,1995,69(9):5 798.
  • 4马艳琴,李光富.CpG DNA的免疫学作用及其应用[J].国外医学(免疫学分册),2003,26(6):318-321. 被引量:7
  • 5Wagstaff NJD,Lilley CE.GE.Gene transfer using a disabled herpes vires vector containing the E MCV IRES allows multiple gene expressiojn in vitro and in vivo[J].Gen Ther,1998,5:1 566-1 570.

二级参考文献19

  • 1Tokunaga T, Yamamoto H, Shimada S, et al. [ J ]. J Nail Cancer Inst,1984,72(4):955-962.
  • 2Krieg AM, Yi AK, Matson S, et al. [J]. Nature, 1995, 374(6) : 546-549.
  • 3Sato Y, Roman M,Tighe H, et al. [ J ].Science, 1996,273 (5273) : 352-354.
  • 4Bauer M, Heeg K, Wagner H, et al. [ J ]. Immunol, 1999,97 (4) : 699-705.
  • 5Takeshita F, Leifer CA, Gursel I, et al. [ J ]. J Immunol, 2001,167 (7) :3555-3558.
  • 6Hemmi H,Takeuchi O,Kawai T.et al. [J]. Nature,2000,408(6813) :740-745.
  • 7Bandhltz L, Guo Y, Palmberg C, et al. [J]. Cell Mol life Sci, 2003,60(2) :422-429.
  • 8Iho S, Yamamoto T,Takahaski T, et al. [ J]. J Immunol. 1999,163(7):3642-3652.
  • 9Hartmann G, Weeratna RD, Ballas ZK,et al. [J] .J Immunol,2000,164(3), 1617-1624.
  • 10Kamstrup S, Verthelyi D, Klinman DM. [J]. Vet Microbiol,2001,78(4) : 353-362.

共引文献6

同被引文献13

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部